In addition, it has also been observed that inhibitory-κB kinase α (IKKα) increases the invasive potential of ErbB2-positive breast cancer cells, which in turn causes ErbB2 to activate NF-κB via the canonical pathway [71]. This evidence concerns the gene NFKB1 and breast carcinoma.